RanBPM inhibits BLT2-mediated IL-8 production and invasiveness in aggressive breast cancer cells

Jun Dong Wei, Jae Hyun Jang, Jae-Hong Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

RanBPM is a scaffolding protein that regulates several cellular processes by interacting with various proteins. Previously, we reported that RanBPM acts as a negative regulator of BLT2, a low-affinity leukotriene B4 receptor; thus, it interferes with BLT2-mediated cell motility. In the present study, we observed that the expression levels of RanBPM were markedly reduced in the highly aggressive MDA-MB-435 and MDA-MB-231 human breast cancer cell lines compared with those in non-invasive MCF-7 cells. Additionally, we found that the restoration of RanBPM levels suppressed the invasiveness of these aggressive breast cancer cells in a manner dependent on BLT2 activation. In contrast, the knockdown of endogenous RanBPM by shRNA strongly promoted invasiveness in non-invasive MCF-7 cells. We also observed that RanBPM suppressed the invasiveness of aggressive breast cancer cells by inhibiting BLT2-mediated reactive oxygen species (ROS) generation and IL-8 production. Taken together, our results suggest that RanBPM acts as a negative regulator of BLT2, thus attenuating the invasiveness of aggressive breast cancer cells.

Original languageEnglish
Pages (from-to)305-311
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume483
Issue number1
DOIs
Publication statusPublished - 2017 Jan 29

Fingerprint

Interleukin-8
Cells
Breast Neoplasms
MCF-7 Cells
Leukotriene B4 Receptors
Ran binding protein 9
Small Interfering RNA
Restoration
Cell Movement
Reactive Oxygen Species
Proteins
Chemical activation
Cell Line

Keywords

  • BLT2
  • Breast cancer
  • IL-8
  • Invasiveness
  • RanBPM

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

RanBPM inhibits BLT2-mediated IL-8 production and invasiveness in aggressive breast cancer cells. / Wei, Jun Dong; Jang, Jae Hyun; Kim, Jae-Hong.

In: Biochemical and Biophysical Research Communications, Vol. 483, No. 1, 29.01.2017, p. 305-311.

Research output: Contribution to journalArticle

@article{0aea8a8418544295a061b0003cd69e40,
title = "RanBPM inhibits BLT2-mediated IL-8 production and invasiveness in aggressive breast cancer cells",
abstract = "RanBPM is a scaffolding protein that regulates several cellular processes by interacting with various proteins. Previously, we reported that RanBPM acts as a negative regulator of BLT2, a low-affinity leukotriene B4 receptor; thus, it interferes with BLT2-mediated cell motility. In the present study, we observed that the expression levels of RanBPM were markedly reduced in the highly aggressive MDA-MB-435 and MDA-MB-231 human breast cancer cell lines compared with those in non-invasive MCF-7 cells. Additionally, we found that the restoration of RanBPM levels suppressed the invasiveness of these aggressive breast cancer cells in a manner dependent on BLT2 activation. In contrast, the knockdown of endogenous RanBPM by shRNA strongly promoted invasiveness in non-invasive MCF-7 cells. We also observed that RanBPM suppressed the invasiveness of aggressive breast cancer cells by inhibiting BLT2-mediated reactive oxygen species (ROS) generation and IL-8 production. Taken together, our results suggest that RanBPM acts as a negative regulator of BLT2, thus attenuating the invasiveness of aggressive breast cancer cells.",
keywords = "BLT2, Breast cancer, IL-8, Invasiveness, RanBPM",
author = "Wei, {Jun Dong} and Jang, {Jae Hyun} and Jae-Hong Kim",
year = "2017",
month = "1",
day = "29",
doi = "10.1016/j.bbrc.2016.12.147",
language = "English",
volume = "483",
pages = "305--311",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - RanBPM inhibits BLT2-mediated IL-8 production and invasiveness in aggressive breast cancer cells

AU - Wei, Jun Dong

AU - Jang, Jae Hyun

AU - Kim, Jae-Hong

PY - 2017/1/29

Y1 - 2017/1/29

N2 - RanBPM is a scaffolding protein that regulates several cellular processes by interacting with various proteins. Previously, we reported that RanBPM acts as a negative regulator of BLT2, a low-affinity leukotriene B4 receptor; thus, it interferes with BLT2-mediated cell motility. In the present study, we observed that the expression levels of RanBPM were markedly reduced in the highly aggressive MDA-MB-435 and MDA-MB-231 human breast cancer cell lines compared with those in non-invasive MCF-7 cells. Additionally, we found that the restoration of RanBPM levels suppressed the invasiveness of these aggressive breast cancer cells in a manner dependent on BLT2 activation. In contrast, the knockdown of endogenous RanBPM by shRNA strongly promoted invasiveness in non-invasive MCF-7 cells. We also observed that RanBPM suppressed the invasiveness of aggressive breast cancer cells by inhibiting BLT2-mediated reactive oxygen species (ROS) generation and IL-8 production. Taken together, our results suggest that RanBPM acts as a negative regulator of BLT2, thus attenuating the invasiveness of aggressive breast cancer cells.

AB - RanBPM is a scaffolding protein that regulates several cellular processes by interacting with various proteins. Previously, we reported that RanBPM acts as a negative regulator of BLT2, a low-affinity leukotriene B4 receptor; thus, it interferes with BLT2-mediated cell motility. In the present study, we observed that the expression levels of RanBPM were markedly reduced in the highly aggressive MDA-MB-435 and MDA-MB-231 human breast cancer cell lines compared with those in non-invasive MCF-7 cells. Additionally, we found that the restoration of RanBPM levels suppressed the invasiveness of these aggressive breast cancer cells in a manner dependent on BLT2 activation. In contrast, the knockdown of endogenous RanBPM by shRNA strongly promoted invasiveness in non-invasive MCF-7 cells. We also observed that RanBPM suppressed the invasiveness of aggressive breast cancer cells by inhibiting BLT2-mediated reactive oxygen species (ROS) generation and IL-8 production. Taken together, our results suggest that RanBPM acts as a negative regulator of BLT2, thus attenuating the invasiveness of aggressive breast cancer cells.

KW - BLT2

KW - Breast cancer

KW - IL-8

KW - Invasiveness

KW - RanBPM

UR - http://www.scopus.com/inward/record.url?scp=85009259968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009259968&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2016.12.147

DO - 10.1016/j.bbrc.2016.12.147

M3 - Article

VL - 483

SP - 305

EP - 311

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 1

ER -